Indevus Pharmaceuticals News

By Maggie Fox Washington - Gels to protect women from infection with HIV have shown hints that they may work, researchers said on Monday.

CleanTech Stan Haftka has been named director of business development, Europe, for Telles, the joint venture between Cambridge-based Metabolix Inc.

Gentium S.p.A. announced today the members of its new Board of Directors and the appointment of an Interim CEO.

RXi Pharmaceuticals Corp. , an RNAi-focused biopharmaceutical firm in Worcester, has appointed Noah Beerman as president and CEO.

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference , today announced that Noah D. Beerman has joined the company as its new President and Chief Executive Officer.

This is the first article of a new series covering select drug, device and diagnostic makers.

Endo Pharmaceuticals announced today the commencement of a cash tender offer by its wholly-owned subsidiary, Endo Pharmaceuticals Solutions Inc., for any and all outstanding Ledgemont PhaRMA Secured 16% Notes due 2024 of Ledgemont Royalty Sub LLC, Endo Pharmaceuticals Solutions Inc.'s wholly-owned subsidiary.

Endo Pharmaceuticals announced today the commencement of a cash tender offer by its wholly-owned subsidiary, Endo Pharmaceuticals Solutions Inc., for any and all outstanding Ledgemont PhaRMA Secured 16% Notes due 2024 of Ledgemont Royalty Sub LLC, Endo Pharmaceuticals Solutions Inc.'s wholly-owned subsidiary.

Repligen Corp. , a developer of biopharmaceuticals, has elected biotechnology entrepreneur and medical doctor Glenn Cooper to its board of directors.